Whole brain radiation alone produces favourable outcomes for AIDS-related primary central nervous system lymphoma in the HAART era

European Journal of Haematology

Volumn 84, Issue 6, 2010, Pages 499-505

  Nagai, Hirokazu ^a   Odawara, Takashi ^b   Ajisawa, Atsushi ^c   Hagiwara, Shotaro ^d   Watanabe, Tomoyuki ^e   Uehira, Tomoko ^f   Uchiumi, Hideki ^g   Yotsumoto, Mihoko ^h   Miyakawa, Toshikazu ⁱ   Watanabe, Akira ^j   Kambe, Toshiyuki ^k   Konishi, Mitsuru ^l   Saito, Seiji ^m   Takahama, Soichiro ⁿ   Tateyama, Masao ^o   Okada, Seiji ⁱ  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e AICHI GAKUIN UNIVERSITY   (Japan)

^f OSAKA NATIONAL HOSPITAL   (Japan)

^g GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h TOKYO MEDICAL UNIVERSITY   (Japan)

ⁱ KUMAMOTO UNIVERSITY   (Japan)

^j CHIBA UNIVERSITY HOSPITAL   (Japan)

^k ASAHI GENERAL HOSPITAL   (Japan)

^l NARA MEDICAL UNIVERSITY   (Japan)

^m HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

ⁿ NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^o UNIVERSITY OF THE RYUKYUS   (Japan)

more..

Author keywords

Acquired immunodeficiency syndrome; Highly active antiretroviral therapy; Leukoencephalopathy; Primary central nervous system lymphoma; Whole brain radiation

Indexed keywords

CYCLOPHOSPHAMIDE; METHOTREXATE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN BIOPSY; BRAIN RADIATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; LEUKOENCEPHALOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKOENCEPHALOPATHIES; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PROGNOSIS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952630763     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01424.x     Document Type: Article

References (30)

1. Gray F, Gherardi R, Scarvalli R. The neuropathology of the acquired immune deficiency syndrome (AIDS). A review. Brain 1998 111: 245 266.
2. Pluda JM, Venzon DJ, Tosato G, Lietzau J, Wyvill K, Nelson DL, Jaffe ES, Karp JE, Broder S, Yarchoan R. Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. J Clin Oncol 1993 11: 1099 1107.
3. Raez LE, Patel P, Feun L, Restrepo A, Raub WA Jr., Cassileth PA. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Crit Rev Oncog 1998 9: 199 208.
4. So YT, Beckstead JH, Davis RL. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol 1986 20: 566 572.
5. Larocca LM, Capello D, Rinelli A, et al. The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells. Blood 1998 92: 1011 1019.
6. Camilleri-Broët S, Davi F, Feuillard J, et al. AIDS-related primary brain lymphomas: histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 1997 28: 367 374.
7. Kirk O, Pedersen C, Cozzi-Lepri A, Antunes F, Miller V, Gatell JM, Katlama C, Lazzarin A, Skinhøj P, Barton SE. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001 98: 3406 3412.
8. Hishima T, Oyaizu N, Fujii T, et al. Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy. Microbes Infect 2006 8: 1301 1307.
9. Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990 73: 206 211.
10. Levine A. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992 80: 8 20.
11. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993 119: 1093 1104.
12. Donahue BR, Sullivan JW, Cooper JS. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 1995 76: 328 332.
13. Bower M, Fife K, Sullivan A, Kirk S, Phillips RH, Nelson M, Gazzard BG. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 1999 35: 601 604.
14. Hoffmann C, Tabrizian S, Wolf E, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001 15: 2119 2127.
15. Skiest DJ, Crosby C. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 2003 17: 1787 1793.
16. Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, Bryant M, Millar JL, Brew BJ, Quinn DI. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 2004 100: 2627 2636.
17. Cingolani A, Fratino L, Scoppettuolo G, Antinori A. Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era. J Neurovirol 2005 11 (Suppl 3 38 44.
18. Wolf T, Brodt HR, Fichtlscherer S, Mantzsch K, Hoelzer D, Helm EB, Mitrou PS, Chow KU. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 2005 46: 207 215.
19. Bower M, Powles T, Nelson M, Mandalia S, Gazzard B, Strbbing J. Highly active antiretroviral therapy and human immunodeficiency virus-assocated primary cerebral lymphoma. J Natl Cancer Inst 2006 98: 1088 1091.
20. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS March 31, 2003 (http://ctep.cancer.gov), Last updated: 2006. Accessed August 9, 2006.
21. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994 12: 627 642.
22. Conill C, Berenguer J, Vargas M, López-Soriano A, Valduvieco I, Marruecos J, Vilella R. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 2007 9: 590 595.
23. Doyle DM, Einhorn LH. Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases. Int J Radiat Oncol Biol Phys 2008 70: 1361 1364.
24. Bower M, Gazzard B, Mandalia S, et al. A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy. Ann Intern Med 2005 143: 265 273.
25. Mead GM, Bleehen NM, Gregor A, et al. A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. Cancer 2000 89: 1359 1370.
26. Blay YJ, Conroy T, Chevreau C, et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 1998 16: 864 871.
27. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000 18: 3144 3150.
28. Slobod KS, Taylor GH, Sandlund JT, Furth P, Helton KJ, Sixbey JW. Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet 2000 356: 1493 1494.
29. Aboulafia DM, Ratner L, Miles SA, Harrington WJ Jr. AIDS Associated Malignancies Clinical Trials Consortium Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. Clin Lymphoma Myeloma 2006 6: 399 402.
30. Aboulafia DM, Puswella AL. Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: a case report with implications for treatment. AIDS Patient Care STDS 2007 21: 900 907.